Huart, C.; Fransolet, M.; Demazy, C.; Le Calvé, B.; Lucas, S.; Michiels, C.; Wéra, A.-C.
Taking Advantage of the Senescence-Promoting Effect of Olaparib after X-ray and Proton Irradiation Using the Senolytic Drug, ABT-263. Cancers 2022, 14, 1460.
https://doi.org/10.3390/cancers14061460
AMA Style
Huart C, Fransolet M, Demazy C, Le Calvé B, Lucas S, Michiels C, Wéra A-C.
Taking Advantage of the Senescence-Promoting Effect of Olaparib after X-ray and Proton Irradiation Using the Senolytic Drug, ABT-263. Cancers. 2022; 14(6):1460.
https://doi.org/10.3390/cancers14061460
Chicago/Turabian Style
Huart, Camille, Maude Fransolet, Catherine Demazy, Benjamin Le Calvé, Stéphane Lucas, Carine Michiels, and Anne-Catherine Wéra.
2022. "Taking Advantage of the Senescence-Promoting Effect of Olaparib after X-ray and Proton Irradiation Using the Senolytic Drug, ABT-263" Cancers 14, no. 6: 1460.
https://doi.org/10.3390/cancers14061460
APA Style
Huart, C., Fransolet, M., Demazy, C., Le Calvé, B., Lucas, S., Michiels, C., & Wéra, A.-C.
(2022). Taking Advantage of the Senescence-Promoting Effect of Olaparib after X-ray and Proton Irradiation Using the Senolytic Drug, ABT-263. Cancers, 14(6), 1460.
https://doi.org/10.3390/cancers14061460